The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
eight of the 15 Alzheimer's disease patients treated with colostranin improved and in the other seven the disease stabilized in contrast I'm reading from the abstract none of the 31 patients from the selenium or Placebo groups with similar mild or moderate Alzheimer's disease improved
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
clostridin was found to be remarkably safe and the results they say were very encouraging and deserve for their research